Insight Molecular Diagnostics, Inc. (IMDX)
3.76
+0.24
(+6.82%)
USD |
NASDAQ |
Apr 24, 16:00
3.76
0.00 (0.00%)
After-Hours: 20:00
Insight Molecular Diagnostics Shareholders Equity (Quarterly) : -31.46M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| FONAR Corp. | 176.93M |
| Interpace Biosciences, Inc. | 22.36M |
| Thermo Fisher Scientific, Inc. | 51.94B |
| XWELL, Inc. | -22.26M |
| Hypha Labs, Inc. | -2.352M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.76M |
| Total Liabilities (Quarterly) | 57.22M |
| Debt to Equity Ratio | -0.1111 |
| Current Ratio | 1.268 |
| Net Debt Paydown Yield | 0.05% |